Latest News

A McGill University–led team developed a prediction model integrating pregnancy-related factors to identify cardiovascular disease risk in women aged 15 to 45.

Recent FDA actions include approvals and clearances in lipid management, CRC screening, contraception, vaginitis testing, and Alzheimer psychosis.

Shpiner examines why physician trust has declined for years and how AI use reflects, not causes, that shift.

Shpiner explains why patients consult AI before a visit and what physicians should do when the tool gets there first.

The FDA-licensed product is room-temperature-stable, rapidly reconstituted, and intended for adult transfusion when other plasma products are unavailable.

Viatris' new once-weekly patch delivers norelgestromin and ethinyl estradiol, with a Pearl Index of 4.14 in the Phase 3 Luminous Study.

As World Hepatitis Day highlights global testing gaps, an expert outlines how primary care can identify at-risk patients sooner.

FDA clearance adds a noninvasive AI-based test for elevated pulmonary capillary wedge pressure to the CorVista System diagnostic platform.